Cargando…
Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
INTRODUCTION: Antiangiogenic agents that inhibit vascular endothelial growth factor have emerged as important tools in cancer therapy and ocular diseases. Their systemic use can induce renal limited microangiopathy. Local use of anti-VEGF agent is supposed to be safe. We report here a unique case of...
Autores principales: | Touzani, F., Geers, C., Pozdzik, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942715/ https://www.ncbi.nlm.nih.gov/pubmed/31934470 http://dx.doi.org/10.1155/2019/2919080 |
Ejemplares similares
-
Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022) -
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022) -
Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022) -
Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021) -
Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice
por: Jo, Dong Hyun, et al.
Publicado: (2015)